Connection

Richard Silver to Male

This is a "connection" page, showing publications Richard Silver has written about Male.
Connection Strength

0.830
  1. PACK syndrome: A case series and review. Am J Med Sci. 2023 04; 365(4):321-328.
    View in: PubMed
    Score: 0.046
  2. Voriconazole-associated periostitis presenting as hypertrophic osteoarthropathy following lung transplantation report of two cases and review of the literature. Semin Arthritis Rheum. 2019 10; 49(2):319-323.
    View in: PubMed
    Score: 0.036
  3. Management of Systemic-Sclerosis-Associated Interstitial Lung Disease. Rheum Dis Clin North Am. 2015 Aug; 41(3):439-57.
    View in: PubMed
    Score: 0.027
  4. Relationship of main pulmonary artery diameter to pulmonary arterial pressure in scleroderma patients with and without interstitial fibrosis. J Comput Assist Tomogr. 2014 Mar-Apr; 38(2):163-8.
    View in: PubMed
    Score: 0.025
  5. Editorial: molecular insights into systemic sclerosis-associated interstitial lung disease. Arthritis Rheumatol. 2014 Mar; 66(3):485-7.
    View in: PubMed
    Score: 0.025
  6. Factors associated with oral hygiene practices among adults with systemic sclerosis. Int J Dent Hyg. 2014 Aug; 12(3):180-6.
    View in: PubMed
    Score: 0.024
  7. Factors associated with gingival inflammation among adults with systemic sclerosis. Int J Dent Hyg. 2014 Feb; 12(1):55-61.
    View in: PubMed
    Score: 0.023
  8. Effect of orofacial exercises on oral aperture in adults with systemic sclerosis. Disabil Rehabil. 2012; 34(1):84-9.
    View in: PubMed
    Score: 0.021
  9. Effect of a multi-faceted intervention on gingival health among adults with systemic sclerosis. Clin Exp Rheumatol. 2011 Mar-Apr; 29(2 Suppl 65):S26-32.
    View in: PubMed
    Score: 0.021
  10. Acute onset of dyspnea in an HIV patient. Am J Med. 2010 Nov; 123(11):999-1000.
    View in: PubMed
    Score: 0.020
  11. Captive of art, not disease. Paul Klee and his illness, scleroderma. Pharos Alpha Omega Alpha Honor Med Soc. 2008; 71(1):16-24.
    View in: PubMed
    Score: 0.016
  12. Down-regulation of collagen and connective tissue growth factor expression with hepatocyte growth factor in lung fibroblasts from white scleroderma patients via two signaling pathways. Arthritis Rheum. 2007 Oct; 56(10):3468-77.
    View in: PubMed
    Score: 0.016
  13. Racial variation in clinical and immunological manifestations of systemic sclerosis. J Rheumatol. 2006 Feb; 33(2):263-8.
    View in: PubMed
    Score: 0.014
  14. Oral sildenafil for the treatment of Raynaud's phenomenon and digital ulcers secondary to systemic sclerosis. Ann Rheum Dis. 2005 Sep; 64(9):1387.
    View in: PubMed
    Score: 0.014
  15. Correlates of depression, including overall and gastrointestinal functional status, among patients with systemic sclerosis. J Rheumatol. 2005 Jan; 32(1):51-7.
    View in: PubMed
    Score: 0.013
  16. Nodular scleroderma: case report and literature review. J Rheumatol. 2003 Nov; 30(11):2500-2.
    View in: PubMed
    Score: 0.012
  17. Patterns of hospital admissions and emergency room visits among patients with scleroderma in South Carolina, USA. J Rheumatol. 2003 Jun; 30(6):1238-43.
    View in: PubMed
    Score: 0.012
  18. Hospital admissions, length of stay, charges, and in-hospital death among patients with systemic sclerosis. J Rheumatol. 2001 Sep; 28(9):2031-7.
    View in: PubMed
    Score: 0.010
  19. Cannabis use while trying to conceive: a prospective cohort study evaluating associations with fecundability, live birth and pregnancy loss. Hum Reprod. 2021 04 20; 36(5):1405-1415.
    View in: PubMed
    Score: 0.010
  20. Hemodynamic effects of epoprostenol in patients with systemic sclerosis and pulmonary hypertension. Chest. 2000 Oct; 118(4):1077-82.
    View in: PubMed
    Score: 0.010
  21. Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial. Ann Rheum Dis. 2020 05; 79(5):618-625.
    View in: PubMed
    Score: 0.010
  22. Systemic sclerosis-associated interstitial lung disease. Lancet Respir Med. 2020 03; 8(3):304-320.
    View in: PubMed
    Score: 0.009
  23. HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry. Proc Natl Acad Sci U S A. 2020 01 07; 117(1):552-562.
    View in: PubMed
    Score: 0.009
  24. Progression of Interstitial Lung Disease in Systemic Sclerosis: The Importance of Pneumoproteins Krebs von den Lungen 6 and CCL18. Arthritis Rheumatol. 2019 12; 71(12):2059-2067.
    View in: PubMed
    Score: 0.009
  25. Randomized Controlled Trial to Evaluate an Internet-Based Self-Management Program in Systemic Sclerosis. Arthritis Care Res (Hoboken). 2019 03; 71(3):435-447.
    View in: PubMed
    Score: 0.009
  26. Risk Factors for Mortality and Cardiopulmonary Hospitalization in Systemic Sclerosis Patients At Risk for Pulmonary Hypertension, in the PHAROS Registry. J Rheumatol. 2019 02; 46(2):176-183.
    View in: PubMed
    Score: 0.009
  27. Brief Report: Whole-Exome Sequencing to Identify Rare Variants and Gene Networks That Increase Susceptibility to Scleroderma in African Americans. Arthritis Rheumatol. 2018 10; 70(10):1654-1660.
    View in: PubMed
    Score: 0.009
  28. Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma. N Engl J Med. 2018 01 04; 378(1):35-47.
    View in: PubMed
    Score: 0.008
  29. Clinical and serological features of systemic sclerosis in a multicenter African American cohort: Analysis of the genome research in African American scleroderma patients clinical database. Medicine (Baltimore). 2017 Dec; 96(51):e8980.
    View in: PubMed
    Score: 0.008
  30. Establishment of an indirect ELISA for detection of the novel antifibrotic peptide M10. PLoS One. 2017; 12(11):e0188588.
    View in: PubMed
    Score: 0.008
  31. There is a need for new systemic sclerosis subset criteria. A content analytic approach. Scand J Rheumatol. 2018 Jan; 47(1):62-70.
    View in: PubMed
    Score: 0.008
  32. Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension. Ann Am Thorac Soc. 2017 May; 14(5):682-689.
    View in: PubMed
    Score: 0.008
  33. Transforming growth factor ?1 (TGF?1)-induced CD44V6-NOX4 signaling in pathogenesis of idiopathic pulmonary fibrosis. J Biol Chem. 2017 06 23; 292(25):10490-10519.
    View in: PubMed
    Score: 0.008
  34. Cytokine concentrations in bronchoalveolar lavage fluid of patients with systemic sclerosis. Arthritis Rheum. 1997 Apr; 40(4):743-51.
    View in: PubMed
    Score: 0.008
  35. Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registry. Clin Exp Rheumatol. 2017 Sep-Oct; 35 Suppl 106(4):106-113.
    View in: PubMed
    Score: 0.008
  36. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial. Lancet Respir Med. 2016 09; 4(9):708-719.
    View in: PubMed
    Score: 0.007
  37. Systemic Sclerosis and Perceptions of Quality in Primary Care. Am J Med Sci. 2016 05; 351(5):447-51.
    View in: PubMed
    Score: 0.007
  38. Genetic susceptibility loci of idiopathic interstitial pneumonia do not represent risk for systemic sclerosis: a case control study in Caucasian patients. Arthritis Res Ther. 2016 Jan 20; 18:20.
    View in: PubMed
    Score: 0.007
  39. M10, a caspase cleavage product of the hepatocyte growth factor receptor, interacts with Smad2 and demonstrates antifibrotic properties in vitro and in vivo. Transl Res. 2016 Apr; 170:99-111.
    View in: PubMed
    Score: 0.007
  40. Eosinophilia-myalgia syndrome: a long-term follow-up study. South Med J. 1995 Sep; 88(9):953-8.
    View in: PubMed
    Score: 0.007
  41. Antinuclear antibody-negative systemic sclerosis. Semin Arthritis Rheum. 2015 Jun; 44(6):680-6.
    View in: PubMed
    Score: 0.007
  42. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia. Curr Opin Rheumatol. 1994 Nov; 6(6):642-9.
    View in: PubMed
    Score: 0.007
  43. Lipopolysaccharide-induced fetal death: the role of tumor-necrosis factor alpha. Biol Reprod. 1994 May; 50(5):1108-12.
    View in: PubMed
    Score: 0.006
  44. Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registry. Arthritis Care Res (Hoboken). 2014 Mar; 66(3):489-95.
    View in: PubMed
    Score: 0.006
  45. Bleomycin delivery by osmotic minipump: similarity to human scleroderma interstitial lung disease. Am J Physiol Lung Cell Mol Physiol. 2014 Apr 15; 306(8):L736-48.
    View in: PubMed
    Score: 0.006
  46. Rationale for anticoagulant therapy of pulmonary fibrosis. Am J Respir Crit Care Med. 2014 Feb 01; 189(3):362-3.
    View in: PubMed
    Score: 0.006
  47. Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis. Am J Hum Genet. 2014 Jan 02; 94(1):47-61.
    View in: PubMed
    Score: 0.006
  48. Overexpression of c-Met and CD44v6 receptors contributes to autocrine TGF-?1 signaling in interstitial lung disease. J Biol Chem. 2014 Mar 14; 289(11):7856-72.
    View in: PubMed
    Score: 0.006
  49. Recognition of pulmonary hypertension in the rheumatology community: lessons from a Quality Enhancement Research Initiative. Clin Exp Rheumatol. 2014 Nov-Dec; 32(6 Suppl 86):S-21-7.
    View in: PubMed
    Score: 0.006
  50. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013 Nov; 72(11):1747-55.
    View in: PubMed
    Score: 0.006
  51. Differential regulation of cell functions by CSD peptide subdomains. Respir Res. 2013 Sep 08; 14:90.
    View in: PubMed
    Score: 0.006
  52. Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease. J Rheumatol. 1993 May; 20(5):838-44.
    View in: PubMed
    Score: 0.006
  53. Endothelial GATA-6 deficiency promotes pulmonary arterial hypertension. Am J Pathol. 2013 Jun; 182(6):2391-406.
    View in: PubMed
    Score: 0.006
  54. Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein. Ann Rheum Dis. 2014 Mar; 73(3):557-66.
    View in: PubMed
    Score: 0.006
  55. Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 years of experience. Cell Transplant. 2013; 22(12):2267-77.
    View in: PubMed
    Score: 0.006
  56. Growth and characterization of fibroblasts obtained from bronchoalveolar lavage of patients with scleroderma. J Rheumatol. 1992 Nov; 19(11):1716-23.
    View in: PubMed
    Score: 0.006
  57. Tryptophan metabolism via the kynurenine pathway in patients with the eosinophilia-myalgia syndrome. Arthritis Rheum. 1992 Sep; 35(9):1097-105.
    View in: PubMed
    Score: 0.006
  58. Use of atorvastatin in systemic lupus erythematosus in children and adolescents. Arthritis Rheum. 2012 Jan; 64(1):285-96.
    View in: PubMed
    Score: 0.005
  59. Neurological deficits during treatment with tumor necrosis factor-alpha antagonists. Am J Med Sci. 2011 Nov; 342(5):352-5.
    View in: PubMed
    Score: 0.005
  60. High resolution computed tomography in early scleroderma lung disease. J Rheumatol. 1991 Oct; 18(10):1520-8.
    View in: PubMed
    Score: 0.005
  61. Anti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysis. J Rheumatol. 2011 Aug; 38(8):1622-30.
    View in: PubMed
    Score: 0.005
  62. Preschool sarcoidosis masquerading as juvenile rheumatoid arthritis: two case reports and a review of the literature. Pediatr Dermatol. 1990 Sep; 7(3):208-13.
    View in: PubMed
    Score: 0.005
  63. Lymphokine activated killer (LAK) cell activity in the peripheral blood lymphocytes of systemic sclerosis (SSc) patients. Clin Exp Rheumatol. 1990 Sep-Oct; 8(5):481-6.
    View in: PubMed
    Score: 0.005
  64. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum. 2010 Aug; 62(8):2467-75.
    View in: PubMed
    Score: 0.005
  65. Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database. J Rheumatol. 2010 Jul; 37(7):1488-501.
    View in: PubMed
    Score: 0.005
  66. Evaluation and management of scleroderma lung disease using bronchoalveolar lavage. Am J Med. 1990 May; 88(5):470-6.
    View in: PubMed
    Score: 0.005
  67. Caveolin-1 regulates leucocyte behaviour in fibrotic lung disease. Ann Rheum Dis. 2010 Jun; 69(6):1220-6.
    View in: PubMed
    Score: 0.005
  68. Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan. N Engl J Med. 1990 Mar 29; 322(13):874-81.
    View in: PubMed
    Score: 0.005
  69. Progressive systemic sclerosis sine scleroderma presenting as pulmonary interstitial fibrosis. Am J Med. 1989 Nov; 87(5):525-7.
    View in: PubMed
    Score: 0.005
  70. Spontaneous production of fibronectin by alveolar macrophages in patients with scleroderma. Arthritis Rheum. 1989 May; 32(5):577-83.
    View in: PubMed
    Score: 0.004
  71. Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort. Arthritis Rheum. 2009 May; 60(5):1496-507.
    View in: PubMed
    Score: 0.004
  72. Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2009 Apr; 60(4):1102-11.
    View in: PubMed
    Score: 0.004
  73. Surfactant protein D and KL-6 as serum biomarkers of interstitial lung disease in patients with scleroderma. J Rheumatol. 2009 Apr; 36(4):773-80.
    View in: PubMed
    Score: 0.004
  74. Childhood dermatomyositis: serial microvascular studies. Pediatrics. 1989 Feb; 83(2):278-83.
    View in: PubMed
    Score: 0.004
  75. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma. J Rheumatol. 2009 Feb; 36(2):330-6.
    View in: PubMed
    Score: 0.004
  76. Antifibrotic properties of caveolin-1 scaffolding domain in vitro and in vivo. Am J Physiol Lung Cell Mol Physiol. 2008 May; 294(5):L843-61.
    View in: PubMed
    Score: 0.004
  77. Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease. Am J Respir Crit Care Med. 2008 Jan 01; 177(1):91-8.
    View in: PubMed
    Score: 0.004
  78. Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease. Am J Respir Crit Care Med. 2007 Nov 15; 176(10):1026-34.
    View in: PubMed
    Score: 0.004
  79. Ethnic disparities among patients with pulmonary hypertension associated with systemic sclerosis. J Rheumatol. 2007 Jun; 34(6):1277-82.
    View in: PubMed
    Score: 0.004
  80. Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis. Ann Rheum Dis. 2007 Dec; 66(12):1641-7.
    View in: PubMed
    Score: 0.004
  81. Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study. Arthritis Rheum. 2007 May; 56(5):1676-84.
    View in: PubMed
    Score: 0.004
  82. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med. 2006 Jun 22; 354(25):2655-66.
    View in: PubMed
    Score: 0.004
  83. Interstitial lung disease in scleroderma. Immune complexes in sera and bronchoalveolar lavage fluid. Arthritis Rheum. 1986 Apr; 29(4):525-31.
    View in: PubMed
    Score: 0.004
  84. Demographic and clinical factors associated with in-hospital death among patients with systemic sclerosis. J Rheumatol. 2005 Oct; 32(10):1888-92.
    View in: PubMed
    Score: 0.003
  85. Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial. J Rheumatol. 2005 May; 32(5):832-40.
    View in: PubMed
    Score: 0.003
  86. Opposing effects of protein kinase Calpha and protein kinase Cepsilon on collagen expression by human lung fibroblasts are mediated via MEK/ERK and caveolin-1 signaling. J Biol Chem. 2005 Apr 08; 280(14):13879-87.
    View in: PubMed
    Score: 0.003
  87. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study. Arthritis Rheum. 2005 Feb; 52(2):592-600.
    View in: PubMed
    Score: 0.003
  88. Interstitial lung disease in scleroderma. Analysis by bronchoalveolar lavage. Arthritis Rheum. 1984 Nov; 27(11):1254-62.
    View in: PubMed
    Score: 0.003
  89. Myofibroblast induction and microvascular alteration in scleroderma lung fibrosis. Clin Exp Rheumatol. 2004 Nov-Dec; 22(6):733-42.
    View in: PubMed
    Score: 0.003
  90. Distinct PKC isoforms mediate cell survival and DNA synthesis in thrombin-induced myofibroblasts. Am J Physiol Lung Cell Mol Physiol. 2005 Jan; 288(1):L190-201.
    View in: PubMed
    Score: 0.003
  91. D-penicillamine induced polymyositis in juvenile chronic arthritis: report of a case. J Rheumatol. 1984 Apr; 11(2):251-2.
    View in: PubMed
    Score: 0.003
  92. Curcumin-induced apoptosis in scleroderma lung fibroblasts: role of protein kinase cepsilon. Am J Respir Cell Mol Biol. 2004 Jul; 31(1):28-35.
    View in: PubMed
    Score: 0.003
  93. Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin. Am J Pathol. 2003 Aug; 163(2):571-81.
    View in: PubMed
    Score: 0.003
  94. Solvent oriented hobbies and the risk of systemic sclerosis. J Rheumatol. 1999 Nov; 26(11):2369-72.
    View in: PubMed
    Score: 0.002
  95. Is occupational organic solvent exposure a risk factor for scleroderma? Arthritis Rheum. 1998 Jun; 41(6):1111-8.
    View in: PubMed
    Score: 0.002
  96. The eosinophilia-myalgia syndrome: status of 205 patients and results of treatment 2 years after onset. Ann Intern Med. 1995 Jun 01; 122(11):851-5.
    View in: PubMed
    Score: 0.002
  97. Fasciitis (not scleroderma) following prolonged exposure to an organic solvent (trichloroethylene). J Rheumatol. 1994 Aug; 21(8):1567-70.
    View in: PubMed
    Score: 0.002
  98. Chest CT in patients with scleroderma: prevalence of asymptomatic esophageal dilatation and mediastinal lymphadenopathy. AJR Am J Roentgenol. 1993 Aug; 161(2):269-72.
    View in: PubMed
    Score: 0.001
  99. Spontaneous dissection of the internal carotid artery in a patient with polyarteritis nodosa. Arthritis Rheum. 1989 Dec; 32(12):1625-6.
    View in: PubMed
    Score: 0.001
  100. Familial clustering of scleroderma spectrum disease. Am J Med. 1988 Jun; 84(6):1023-32.
    View in: PubMed
    Score: 0.001
  101. Treatment of early chronic lymphocytic leukemia: intermittent chlorambucil versus observation. Hematol Oncol. 1988 Jan-Mar; 6(1):7-12.
    View in: PubMed
    Score: 0.001
  102. Mononuclear cells from rheumatoid arthritis patients exhibit a depressed IgM response to sheep erythrocyte stimulation in vitro. Diagn Clin Immunol. 1988; 5(5):266-8.
    View in: PubMed
    Score: 0.001
  103. Dipyridamole decreases platelet-derived growth factor levels in human serum. Arteriosclerosis. 1987 Mar-Apr; 7(2):152-8.
    View in: PubMed
    Score: 0.001
  104. Anticentromere antibody and immunoglobulin allotypes in scleroderma. Arch Dermatol. 1985 Mar; 121(3):339-44.
    View in: PubMed
    Score: 0.001
  105. Direct and indirect immunofluorescent findings in dermatomyositis. J Cutan Pathol. 1985 Feb; 12(1):18-27.
    View in: PubMed
    Score: 0.001
  106. Fibronectin distribution in nailfold biopsies of scleroderma (systemic sclerosis) patients. Acta Derm Venereol. 1985; 65(3):185-9.
    View in: PubMed
    Score: 0.001
  107. Epidermal nuclear immunofluorescence: serological correlations supporting an in vivo reaction. Br J Dermatol. 1985 Jan; 112(1):15-22.
    View in: PubMed
    Score: 0.001
  108. Immunofluorescence in skin specimens from three different biopsy sites in patients with scleroderma. Clin Exp Rheumatol. 1985 Jan-Mar; 3(1):11-6.
    View in: PubMed
    Score: 0.001
  109. Association between fluorescent antinuclear antibodies, capillary patterns, and clinical features in scleroderma spectrum disorders. Am J Med. 1984 Nov; 77(5):812-22.
    View in: PubMed
    Score: 0.001
  110. Serial changes in nailfold capillary morphology in childhood dermatomyositis. Arthritis Rheum. 1983 Sep; 26(9):1169-72.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.